The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.75
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.90 (4.918%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 18.75
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares and TVR

19 Dec 2022 07:00

RNS Number : 0773K
BATM Advanced Communications Ld
19 December 2022
 

LEI: 213800FLQUB9J289RU66

19 December 2022

 

BATM Advanced Communications Limited

("BATM" or "the Company")

 

Transaction in own shares

and Total Voting Rights

 

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that it purchased 350,000 ordinary shares of NIS 0.01 each in the Company ("Ordinary Shares") via the Company's broker, Shore Capital Stockbrokers Limited ("Shore Capital Stockbrokers"), as detailed below. The repurchased Ordinary Shares will be held in treasury.

 

Date of purchase:

16 December 2022

Aggregate number of ordinary shares purchased:

350,000

Lowest price paid per share (pence):

22.56

Highest price paid per share (pence):

22.56

Volume weighted average price paid per share (pence):

22.56

Treatment of purchased shares:

Held in treasury

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Shore Capital Stockbrokers as part of the Company's share buyback programme.

 

Individual transactions:

 

Transaction date and time

Number of Ordinary Shares purchased

Transaction price (pence per share)

Trading venue

16 December 2022

350,000

22.56p

LSE

 

Following settlement of the above transaction, the Company's issued share capital will comprise 440,534,124 Ordinary Shares, including 4,095,000 Ordinary Shares held in treasury.

 

Therefore, the figure of 436,439,124 Ordinary Shares should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018). 

 

Enquiries:

 

BATM Advanced Communications

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

 

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

 

+44 20 7408 4050 

 

Gracechurch Group

Harry Chathli, Claire Norbury

+44 20 4582 3500

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUWUKRUSUUAAA
Date   Source Headline
26th Nov 202012:21 pmRNSBlock Listing Interim Review
23rd Nov 202011:58 amRNSNotice of AGM
5th Oct 20207:00 amRNSMajor new customer for COVID-19 diagnostic tests
27th Aug 20207:00 amRNSBATM secures first tier 1 customer for NFVTime
17th Aug 20207:00 amRNSInterim Results
6th Aug 20206:16 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSNotice of Results
5th Aug 20208:09 amRNSSuccessful proof-of-concept with Vodafone
15th Jul 20207:00 amRNSBATM expands COVID-19 diagnostic tests
25th Jun 20207:00 amRNSBusiness and Trading Update
4th Jun 202012:01 pmRNSHolding(s) in Company
26th May 20207:00 amRNSBlock Listing Application
6th May 202011:45 amRNSHolding(s) in Company
5th May 20207:00 amRNSBATM Launches Antibody Tests for COVID-19
30th Apr 20204:33 pmRNSAnnual Financial Report - DTR 6.3.5 Disclosure
30th Apr 20207:00 amRNSCOVID-19 Update
22nd Apr 20207:00 amRNSBATM receives c. $31m order to produce ventilators
19th Mar 20207:00 amRNSNovamed partnership for COVID-19 diagnostics kit
6th Mar 20207:00 amRNSHolding(s) in Company
4th Mar 20207:00 amRNSFull Year Results
27th Feb 20207:00 amRNSBATM Develops Diagnostics Kit for COVID-19
24th Feb 20207:00 amRNSAward of $4m follow-on cyber contract
12th Feb 20207:00 amRNSNotice of Results
10th Feb 20207:00 amRNSThird international agri-waste contract
7th Feb 20207:00 amRNSHolding(s) in Company
23rd Jan 202011:43 amRNSHolding(s) in Company
22nd Jan 20205:54 pmRNSHolding(s) in Company
7th Jan 20207:00 amRNSFirst commercial agreement for Ador
5th Dec 20193:49 pmRNSResult of AGM
5th Dec 20197:00 amRNS$4m agri-waste treatment contract in Taiwan
7th Nov 20197:00 amRNSNotice of AGM
8th Oct 20197:00 amRNSDirector Share Purchases
7th Oct 20197:00 amRNSExpansion of cyber offering and follow-on contract
2nd Oct 20197:00 amRNSBATM completes delivery under Arm agreement
10th Sep 20197:00 amRNSDirector Shareholding, Issue of Equity and TVR
2nd Sep 20192:19 pmRNSHolding(s) in Company
23rd Aug 20197:00 amRNSBATM joins Tel-Aviv Stock Exchange indices
20th Aug 20192:34 pmRNSHolding(s) in Company
19th Aug 20197:00 amRNSInterim Results
7th Aug 201911:11 amRNSShare Option Exercise, Issue of Equity and TVR
5th Aug 20197:00 amRNSNotice of Results
31st Jul 20192:45 pmRNSReceipt of c. $3.4m from sale of IBC holding
22nd Jul 20197:00 amRNSBATM Advances 5G Strategy with New T-Metro 8104
11th Jul 20199:20 amRNSFirst Day Dealings on the Tel Aviv Stock Exchange
11th Jul 20197:45 amRNSFirst Day Dealings on the Tel Aviv Stock Exchange
8th Jul 20197:00 amRNSSecondary Listing on the Tel Aviv Stock Exchange
25th Jun 20198:28 amRNSResults of Placing and Subscription
24th Jun 20195:26 pmRNSProposed Fundraise to raise a minimum of US$15m
17th Jun 20197:00 amRNSNew solution under NXP Semiconductors partnership
10th Jun 20197:00 amRNSBATM Cyber Security Partnership with Clavister

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.